Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection

[1]  J. Leung,et al.  Cannabis use in Sub-Saharan Africa: a systematic review and meta-analysis. , 2023, Addiction.

[2]  P. Petersen Williams.  Liberalising cannabis legislation in South Africa: cautions to include breastfeeding mothers. , 2022, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[3]  E. Mazzon,et al.  The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease , 2022, Biomedicines.

[4]  Chi-Tang Ho,et al.  The impact of phyto- and endo-cannabinoids on central nervous system diseases：A review , 2022, Journal of traditional and complementary medicine.

[5]  R. A. de Melo Reis,et al.  Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice , 2022, Frontiers in Cellular Neuroscience.

[6]  H. Koltai,et al.  Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action , 2022, Frontiers in Pharmacology.

[7]  S. Pichini,et al.  Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis. , 2022, Journal of pharmaceutical and biomedical analysis.

[8]  O. Blin,et al.  What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps? , 2022, Frontiers in Pharmacology.

[9]  Man Li,et al.  Inflammation-targeted cannabidiol-loaded nanomicelles for enhanced oral mucositis treatment , 2022, Drug delivery.

[10]  J. Wilkerson,et al.  Medicinal Cannabis and Central Nervous System Disorders , 2022, Frontiers in Pharmacology.

[11]  A. Petzer,et al.  An assessment of solvent residue contaminants related to cannabis-based products in the South African market , 2022, Journal of Cannabis Research.

[12]  C. Laezza,et al.  Cannabinoids: Therapeutic Use in Clinical Practice , 2022, International journal of molecular sciences.

[13]  Jeremy Y. Ng,et al.  The medical cannabis regulatory framework in Canada: A narrative review , 2022, European Journal of Integrative Medicine.

[14]  Di Wu,et al.  Cannabis sativa Bioactive Compounds and Their Extraction, Separation, Purification, and Identification Technologies: An Updated Review , 2022, TrAC Trends in Analytical Chemistry.

[15]  G. Stefkov,et al.  Analytical Techniques for Phytocannabinoid Profiling of Cannabis and Cannabis-Based Products—A Comprehensive Review , 2022, Molecules.

[16]  Muhammad A. Alsherbiny,et al.  A Comprehensive Review on the Techniques for Extraction of Bioactive Compounds from Medicinal Cannabis , 2022, Molecules.

[17]  H. Parekh,et al.  Fractional Factorial Design Study for the Extraction of Cannabinoids from CBD-Dominant Cannabis Flowers by Supercritical Carbon Dioxide , 2022, Processes.

[18]  T. Songsak,et al.  Optimization of supercritical carbon dioxide fluid extraction of seized cannabis and self-emulsifying drug delivery system for enhancing the dissolution of cannabis extract , 2022, The Journal of Supercritical Fluids.

[19]  Umut Karğılı,et al.  Supercritical fluid extraction of cannabinoids (THC and CBD) from four different strains of cannabis grown in different regions , 2022, The Journal of Supercritical Fluids.

[20]  Z. Bhat,et al.  Applications of Cannabis Sativa L. in Food and Its Therapeutic Potential: From a Prohibited Drug to a Nutritional Supplement , 2021, Molecules.

[21]  G. Biagini,et al.  Antiseizure Effects of Fully Characterized Non-Psychoactive Cannabis sativa L. Extracts in the Repeated 6-Hz Corneal Stimulation Test , 2021, Pharmaceuticals.

[22]  A. Dalai,et al.  Cannabis: Chemistry, extraction and therapeutic applications. , 2021, Chemosphere.

[23]  M. Desimone,et al.  Collagen Hydrogels Loaded with Silver Nanoparticles and Cannabis Sativa Oil , 2021, Antibiotics.

[24]  O. Kayser,et al.  Cannabis sativa research trends, challenges, and new-age perspectives , 2021, iScience.

[25]  M. Lefsrud,et al.  Cannabis chemistry, post-harvest processing methods and secondary metabolite profiling: A review , 2021 .

[26]  Stefano Amaducci,et al.  Ranking 26 European hemp (Cannabis sativa L.) cultivars for osmotic stress tolerance and transpiration efficiency , 2021 .

[27]  A. Seyfoddin,et al.  Processing and extraction methods of medicinal cannabis: a narrative review , 2021, Journal of Cannabis Research.

[28]  V. Socoliuc,et al.  Green Synthesis, Characterization, and Antibacterial Properties of Silver Nanoparticles Obtained by Using Diverse Varieties of Cannabis sativa Leaf Extracts , 2021, Molecules.

[29]  An Silva,et al.  Medicinal uses of Cannabis sp. , 2021, Research, Society and Development.

[30]  C. Page,et al.  The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. , 2021, Pulmonary pharmacology & therapeutics.

[31]  A. Shahbazi,et al.  Extraction of Cannabinoids from Cannabis sativa L. (Hemp)—Review , 2021, Agriculture.

[32]  Jan Rožanc,et al.  Different Cannabis sativa Extraction Methods Result in Different Biological Activities against a Colon Cancer Cell Line and Healthy Colon Cells , 2021, Plants.

[33]  Cannabis use and cannabis use disorder , 2021, Nature Reviews Disease Primers.

[34]  H. Parekh,et al.  Extraction of medicinal cannabinoids through supercritical carbon dioxide technologies: A review. , 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[35]  F. Shahidi,et al.  Cannabis and Cannabis Edibles: A Review. , 2021, Journal of agricultural and food chemistry.

[36]  S. Shi,et al.  Green Synthesis of Silver Nanoparticles Using Cannabis sativa Extracts and Their Anti-Bacterial Activity , 2021 .

[37]  T. Bujak,et al.  Positive Effect of Cannabis sativa L. Herb Extracts on Skin Cells and Assessment of Cannabinoid-Based Hydrogels Properties , 2021, Molecules.

[38]  P. Sampson.  Phytocannabinoid Pharmacology: Medicinal Properties of Cannabis sativa Constituents Aside from the "Big Two". , 2020, Journal of natural products.

[39]  Felipe Patricio,et al.  Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease , 2020, Frontiers in Pharmacology.

[40]  R. Lines,et al.  New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries , 2020, Harm Reduction Journal.

[41]  E. Reverchon,et al.  Supercritical fluid technologies applied to the extraction of compounds of industrial interest from Cannabis sativa L. and to their pharmaceutical formulations: A review , 2020 .

[42]  J. Mlost,et al.  Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action , 2020, International journal of molecular sciences.

[43]  L. Verotta,et al.  Cannabidiol from inflorescences of Cannabis sativa L.: Green extraction and purification processes , 2020 .

[44]  Y. Korchev,et al.  CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons , 2020, Journal of pain research.

[45]  C. Viegas,et al.  Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases , 2020, Current neuropharmacology.

[46]  B. Møller,et al.  Phytocannabinoids: Origins and Biosynthesis. , 2020, Trends in plant science.

[47]  J. King,et al.  Extraction of cannabinoids from hemp (Cannabis sativa L.) using high pressure solvents: An overview of different processing options , 2020 .

[48]  G. Spangenberg,et al.  Utilisation of Design of Experiments Approach to Optimise Supercritical Fluid Extraction of Medicinal Cannabis , 2020, Scientific Reports.

[49]  V. Di Marzo,et al.  Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent , 2020, Cannabis and cannabinoid research.

[50]  G. Zengin,et al.  Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes , 2020, International journal of molecular sciences.

[51]  N. Teixeira,et al.  Cannabis sativa: much more beyond Δ9-tetrahydrocannabinol. , 2020, Pharmacological research.

[52]  A. Shahbazi,et al.  A Review on the Current State of Knowledge of Growing Conditions, Agronomic Soil Health Practices and Utilities of Hemp in the United States , 2020, Agriculture.

[53]  Pellegrino Cerino,et al.  A Review of Hemp as Food and Nutritional Supplement. , 2020, Cannabis and cannabinoid research.

[54]  K. Znajdek,et al.  A Guide to Targeting the Endocannabinoid System in Drug Design , 2020, International journal of molecular sciences.

[55]  E. Cukrowska,et al.  Selective Extraction of Cannabinoid Compounds from Cannabis Seed Using Pressurized Hot Water Extraction , 2020, Molecules.

[56]  M. Bulsara,et al.  Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia: study protocol for a double-blind randomised crossover trial , 2020, Trials.

[57]  J. Carretero,et al.  Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro , 2020, PloS one.

[58]  E. Aronica,et al.  Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission? , 2020, International journal of molecular sciences.

[59]  I. Arévalo-Rodriguez,et al.  Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews , 2020, BMC Complementary Medicine and Therapies.

[60]  S. Atalay,et al.  Antioxidative and Anti-Inflammatory Properties of Cannabidiol , 2019, Antioxidants.

[61]  M. Maccarrone.  Missing Pieces to the Endocannabinoid Puzzle. , 2019, Trends in molecular medicine.

[62]  M. J. Vazquez,et al.  Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity. , 2019, Biochemical pharmacology.

[63]  D. Friedman,et al.  Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders , 2019, The Lancet Neurology.

[64]  J. King,et al.  Extraction, isolation and purification of tetrahydrocannabinol from the Cannabis sativa L. plant using supercritical fluid extraction and solid phase extraction , 2019, The Journal of Supercritical Fluids.

[65]  A. Duarte,et al.  Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination , 2019, Medicines.

[66]  P. Griffiths,et al.  Increasing potency and price of cannabis in Europe, 2006–16 , 2019, Addiction.

[67]  P. Morales,et al.  Cannabinoid Ligands Targeting TRP Channels , 2019, Front. Mol. Neurosci..

[68]  C. Lucas,et al.  The pharmacokinetics and the pharmacodynamics of cannabinoids. , 2018, British journal of clinical pharmacology.

[69]  S. Benvenuti,et al.  New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp) , 2018, Molecules.

[70]  S. Oliaro-Bosso,et al.  Cannabinoid Delivery Systems for Pain and Inflammation Treatment , 2018, Molecules.

[71]  Mi-Young Lee,et al.  The ameliorative effect of hemp seed hexane extracts on the Propionibacterium acnes-induced inflammation and lipogenesis in sebocytes , 2018, PloS one.

[72]  M. Matsabisa,et al.  Priority areas for cannabis and cannabinoid product research in South Africa , 2018, African journal of primary health care & family medicine.

[73]  A. Djamshidian,et al.  Cannabinoids for Treatment of Dystonia in Huntington's Disease. , 2018, Journal of Huntington's disease.

[74]  J. Maroon,et al.  Review of the neurological benefits of phytocannabinoids , 2018, Surgical neurology international.

[75]  L. Shbiro,et al.  Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America. , 2018, European journal of internal medicine.

[76]  Niccolo V. Aieta,et al.  Supercritical carbon dioxide extraction of cannabinoids from Cannabis sativa L. , 2017 .

[77]  L. Puljak,et al.  Cannabinoids for the treatment of dementia. , 2017, Cochrane Database of Systematic Reviews.

[78]  W. Catterall,et al.  Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome , 2017, Proceedings of the National Academy of Sciences.

[79]  R. Basir,et al.  Delta-9-Tetrahydrocannabinol (∆9-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats , 2017, Neurotoxicity Research.

[80]  Danielle M. Morabito,et al.  Cannabis, Cannabinoids, and Sleep: a Review of the Literature , 2017, Current Psychiatry Reports.

[81]  Larissa Leite Barboza,et al.  O Uso do Canabidiol no Tratamento da Epilepsia , 2017 .

[82]  T. Karl,et al.  In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease , 2017, Front. Pharmacol..

[83]  V. Lelong-Boulouard,et al.  Focus on cannabinoids and synthetic cannabinoids , 2017, Clinical pharmacology and therapeutics.

[84]  F. Guimarães,et al.  Cannabidiol, neuroprotection and neuropsychiatric disorders. , 2016, Pharmacological research.

[85]  Núbia Verçosa de Figueiredo,et al.  Derivados canabinóides e o tratamento farmacológico da dor , 2016 .

[86]  Penny F Whiting,et al.  Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. , 2015, JAMA.

[87]  V Kiran Vemuri,et al.  Medicinal chemistry of cannabinoids , 2015, Clinical pharmacology and therapeutics.

[88]  A. Elaissari,et al.  Essential oils: from extraction to encapsulation. , 2015, International journal of pharmaceutics.

[89]  M. Cascio,et al.  Known Pharmacological Actions of Delta-9-Tetrahydrocannabinol and of Four Other Chemical Constituents of Cannabis that Activate Cannabinoid Receptors , 2014 .

[90]  L. Steardo,et al.  Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement , 2011, PloS one.

[91]  Ethan B. Russo.  Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects , 2011, British journal of pharmacology.

[92]  Benjamin J. Whalley,et al.  Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures , 2011, Seizure.

[93]  Stephen P. H. Alexander,et al.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 , 2010, Pharmacological Reviews.

[94]  Ludo Waltman,et al.  Software survey: VOSviewer, a computer program for bibliometric mapping , 2009, Scientometrics.

[95]  A. Zuardi.  Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. , 2008, Revista brasileira de psiquiatria.

[96]  B. Minke.  TRP channels and Ca2+ signaling. , 2006, Cell calcium.

[97]  E. Russo,et al.  Agonistic Properties of Cannabidiol at 5-HT1a Receptors , 2005, Neurochemical Research.

[98]  R. Lipton,et al.  Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials , 2001, The Lancet.

[99]  D. Ponde,et al.  Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide , 2001, British journal of pharmacology.

[100]  J. Proops,et al.  Industrial hemp's double dividend: a study for the USA , 1998 .

[101]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .

[102]  D. Neumann,et al.  The endocannabinoid system: Overview of an emerging multi-faceted therapeutic target. , 2019, Prostaglandins, leukotrienes, and essential fatty acids.

[103]  D. Centonze,et al.  The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases , 2018, Progress in Neurobiology.

[104]  J. Marcu,et al.  Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads. , 2017, Advances in pharmacology.

[105]  J. Ramos,et al.  Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others. , 2015, Handbook of experimental pharmacology.

[106]  R. Hamill,et al.  Parkinson's disease. , 2012, Sub-cellular biochemistry.

[107]  G. Guy,et al.  A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. , 2006, Medical hypotheses.